Want to see IN:AARTIDRUGS full AI Analyst Report?
Total Valuation
Aarti Drugs Limited has a market cap or net worth of ₹39.87B. The enterprise value is ₹34.83K.
Market Cap₹39.87B
Enterprise Value₹34.83K
Share Statistics
Aarti Drugs Limited has 91,270,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding91,270,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aarti Drugs Limited’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.12%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)10.12%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee24.11M
Profits Per Employee1.83M
Employee Count1,064
Asset Turnover0.91
Inventory Turnover3.70
Valuation Ratios
The current PE Ratio of Aarti Drugs Limited is 20.5. Aarti Drugs Limited’s PEG ratio is 0.91.
PE Ratio20.5
PS Ratio1.14
PB Ratio1.88
Price to Fair Value1.88
Price to FCF59.44
Price to Operating Cash Flow25.67
PEG Ratio0.91
Income Statement
In the last 12 months, Aarti Drugs Limited had revenue of 25.65B and earned 1.95B in profits. Earnings per share was 21.36.
Revenue25.65B
Gross Profit7.50B
Operating Income2.42B
Pretax Income2.11B
Net Income1.95B
EBITDA3.12B
Earnings Per Share (EPS)21.36
Cash Flow
In the last 12 months, operating cash flow was 1.52B and capital expenditures -943.10M, giving a free cash flow of 580.50M billion.
Operating Cash Flow1.52B
Free Cash Flow580.50M
Free Cash Flow per Share6.36
Dividends & Yields
Aarti Drugs Limited pays an annual dividend of ₹2, resulting in a dividend yield of 0.47%
Dividend Per Share₹2
Dividend Yield0.47%
Payout Ratio9.55%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.88
52-Week Price Change-15.50%
50-Day Moving Average414.31
200-Day Moving Average387.16
Relative Strength Index (RSI)60.68
Average Volume (3m)12.26K
Important Dates
Aarti Drugs Limited upcoming earnings date is Oct 22, 2026, TBA (Confirmed).
Last Earnings DateJul 31, 2026
Next Earnings DateOct 22, 2026
Ex-Dividend Date―
Financial Position
Aarti Drugs Limited as a current ratio of 1.59, with Debt / Equity ratio of 37.23%
Current Ratio1.59
Quick Ratio1.06
Debt to Market Cap0.20
Net Debt to EBITDA1.82
Interest Coverage Ratio7.19
Taxes
In the past 12 months, Aarti Drugs Limited has paid 159.60M in taxes.
Income Tax159.60M
Effective Tax Rate0.08
Enterprise Valuation
Aarti Drugs Limited EV to EBITDA ratio is 11.19, with an EV/FCF ratio of 71.01.
EV to Sales1.36
EV to EBITDA11.19
EV to Free Cash Flow71.01
EV to Operating Cash Flow15.67
Balance Sheet
Aarti Drugs Limited has ₹242.80M in cash and marketable securities with ₹5.77B in debt, giving a net cash position of -₹5.52B billion.
Cash & Marketable Securities₹242.80M
Total Debt₹5.77B
Net Cash-₹5.52B
Net Cash Per Share-₹60.52
Tangible Book Value Per Share₹167.97
Margins
Gross margin is 31.68%, with operating margin of 9.44%, and net profit margin of 7.60%.
Gross Margin31.68%
Operating Margin9.44%
Pretax Margin8.22%
Net Profit Margin7.60%
EBITDA Margin12.15%
EBIT Margin9.54%
Analyst Forecast
The average price target for Aarti Drugs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10.54%
EPS Growth Forecast1.27%